Rubella IgM ELISA Kit, Single from Bio-Quant Inc.
EBV-VCA IgA ELISA Kit, Single from Bio-Quant Inc.
H. Pylori IgM ELISA Kit, Single from Bio-Quant Inc.
Mouse IgG2b EIA Kit from Assay Designs/Stressgen Bioreagents
Biology Products:(Date:11/20/2009)...ehigh University,s Energy Research Center (ERC) ha... Energy (DOE) to develop methods of recovering and...arbon-dioxide (CO 2 ) compression process in a car...ct is to facilitate carbon capture and sequestrati... CO 2 , a greenhouse gas, emitted into the atmosph...
(Date:11/19/2009)...t,s a naturally occurring brain chemical with an u...outh, it can be abused or used as a date-rape drug... have determined new routes by which 4-HB is metab...ormation," said K. Michael Gibson, professor and c...cal University and a member of the research team. ...
(Date:11/19/2009)...ADISON Leaf-cutter ants, which cultivate fungus f...,s a new one to add to the list: the ant farmers, ...fixing bacteria to make their gardens grow. The fi... Science , documents a previously unknown symbios...into how leaf-cutter ants have come to dominate th...
Breaking Biology News(10 mins):Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Researchers begin to decipher metabolism of sexual assault drug 2Like humans, ants use bacteria to make their gardens grow 2Scientists open doors to diagnosis of emphysema 9456 1Scientists open doors to diagnosis of emphysema 9456 2Webcast Alert 3A Medial Saude S A Announces Second Quarter 2009 Earnings Conference Call Webcast 53485 1SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 1SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 2SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 3SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 5... starship Enterprise would deploy a deflector shie...of switching on a molecular force field of their o...ow University of Florida researchers have found a ...yme that bonds with a protein, creating a protecti...chemotherapy and promotes tumor cell survival. But...
... high levels of antibodies against the Epstein-Bar...eosis, may be more likely to develop multiple scle...osted online today that will appear in the June 20...e JAMA/Archives journals. , Researchers have long ...risk for multiple sclerosis (MS), a chronic autoim...
...T have found a new way of looking beneath the ocea...hether fish populations are shrinking. , A remote ...holas Makris of mechanical engineering, along with...val Research Laboratory, allows scientists to trac... small schools, over a 10,000-square-kilometer are...
Other Biology News:Molecular force field helps cancer cells defend against attack 2Molecular force field helps cancer cells defend against attack 3Big hips, big belly? It's in your genes, Joslin-led study shows 2One fish, two fish: New MIT sensor improves fish counts 2(Date:11/20/2009)... , , SEATTLE, Nov. 20 /PRNewswire-FirstCa... announced that the U.S. Food and Drug Administrat...e Company,s amended Biologics License Application ...ete response. The FDA has assigned a Prescription... which time it will respond to Dendreon,s amended ...
(Date:11/20/2009)... , METTLER TOLEDO recentl...nt a free webinar, “The Role of Process Anal...en Engineering” on December 1, 2009. , ...uring the The Role of Process Analytical Technolo...Webinar on December 1, Process Analytical Technol...
(Date:11/19/2009)... , , ,, BETHESDA, Md., Nov. 19 /P...aq: SPEX ), an innovator in biotechnology for dia...ulatory consulting services to food, supplement, b...ed today it closed the previously reported $6.3 mi... investors of 2,760,870 shares of its common stock...
(Date:11/19/2009)... , , MONTREAL, Nov. 19 /PRNewswire/ - Aege... the first patient in a randomized Phase 2B study ...id-stage development for multiple oncology indicat...domized Phase 2 Study of the X-Linked Inhibitor of...ination with High-dose Cytarabine and Idarubicin i...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2